• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于临床参数和磁共振成像放射组学组合模型预测宫颈癌放化疗后野外复发:日本放射肿瘤学研究组的多机构研究。

Prediction of out-of-field recurrence after chemoradiotherapy for cervical cancer using a combination model of clinical parameters and magnetic resonance imaging radiomics: a multi-institutional study of the Japanese Radiation Oncology Study Group.

出版信息

J Radiat Res. 2022 Jan 20;63(1):98-106. doi: 10.1093/jrr/rrab104.

DOI:10.1093/jrr/rrab104
PMID:34865079
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8776693/
Abstract

We retrospectively assessed whether magnetic resonance imaging (MRI) radiomics combined with clinical parameters can improve the predictability of out-of-field recurrence (OFR) of cervical cancer after chemoradiotherapy. The data set was collected from 204 patients with stage IIB (FIGO: International Federation of Gynecology and Obstetrics 2008) cervical cancer who underwent chemoradiotherapy at 14 Japanese institutes. Of these, 180 patients were finally included for analysis. OFR-free survival was calculated using the Kaplan-Meier method, and the statistical significance of clinicopathological parameters for the OFR-free survival was evaluated using the log-rank test and Cox proportional-hazards model. Prediction of OFR from the analysis of diffusion-weighted images (DWI) and T2-weighted images of pretreatment MRI was done using the least absolute shrinkage and selection operator (LASSO) model for engineering image feature extraction. The accuracy of prediction was evaluated by 5-fold cross-validation of the receiver operating characteristic (ROC) analysis. Para-aortic lymph node metastasis (p = 0.003) was a significant prognostic factor in univariate and multivariate analyses. ROC analysis showed an area under the curve (AUC) of 0.709 in predicting OFR using the pretreatment status of para-aortic lymph node metastasis, 0.667 using the LASSO model for DWIs and 0.602 using T2 weighted images. The AUC improved to 0.734 upon combining the pretreatment status of para-aortic lymph node metastasis with that from the LASSO model for DWIs. Combining MRI radiomics with clinical parameters improved the accuracy of predicting OFR after chemoradiotherapy for locally advanced cervical cancer.

摘要

我们回顾性评估了磁共振成像(MRI)放射组学结合临床参数是否可以提高宫颈癌放化疗后野外复发(OFR)的预测能力。该数据集来自在 14 家日本机构接受放化疗的 204 名 IIB 期(FIGO:国际妇产科联合会 2008 年)宫颈癌患者。其中,最终有 180 名患者被纳入分析。采用 Kaplan-Meier 法计算 OFR 无复发生存率,采用对数秩检验和 Cox 比例风险模型评估临床病理参数对 OFR 无复发生存率的统计学意义。采用最小绝对值收缩和选择算子(LASSO)模型对弥散加权成像(DWI)和预处理 MRI 的 T2 加权图像进行分析,对 OFR 进行预测。通过Receiver Operating Characteristic(ROC)分析的 5 倍交叉验证评估预测的准确性。腹主动脉旁淋巴结转移(p=0.003)是单因素和多因素分析中的显著预后因素。ROC 分析显示,使用腹主动脉旁淋巴结转移的预处理状态预测 OFR 的曲线下面积(AUC)为 0.709,使用 DWI 的 LASSO 模型为 0.667,使用 T2 加权图像为 0.602。当将腹主动脉旁淋巴结转移的预处理状态与 DWI 的 LASSO 模型结合使用时,AUC 提高至 0.734。将 MRI 放射组学与临床参数相结合,提高了局部晚期宫颈癌放化疗后 OFR 的预测准确性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e72/8776693/740921d6cff5/rrab104f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e72/8776693/f075817dd5bb/rrab104f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e72/8776693/8377be681ec5/rrab104f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e72/8776693/caa34248a28c/rrab104f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e72/8776693/ef3cd44b6870/rrab104f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e72/8776693/740921d6cff5/rrab104f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e72/8776693/f075817dd5bb/rrab104f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e72/8776693/8377be681ec5/rrab104f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e72/8776693/caa34248a28c/rrab104f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e72/8776693/ef3cd44b6870/rrab104f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e72/8776693/740921d6cff5/rrab104f5.jpg

相似文献

1
Prediction of out-of-field recurrence after chemoradiotherapy for cervical cancer using a combination model of clinical parameters and magnetic resonance imaging radiomics: a multi-institutional study of the Japanese Radiation Oncology Study Group.基于临床参数和磁共振成像放射组学组合模型预测宫颈癌放化疗后野外复发:日本放射肿瘤学研究组的多机构研究。
J Radiat Res. 2022 Jan 20;63(1):98-106. doi: 10.1093/jrr/rrab104.
2
Prediction of outcome using pretreatment F-FDG PET/CT and MRI radiomics in locally advanced cervical cancer treated with chemoradiotherapy.使用预处理 F-FDG PET/CT 和 MRI 放射组学预测接受放化疗的局部晚期宫颈癌的结局。
Eur J Nucl Med Mol Imaging. 2018 May;45(5):768-786. doi: 10.1007/s00259-017-3898-7. Epub 2017 Dec 9.
3
MRI-based radiomics value for predicting the survival of patients with locally advanced cervical squamous cell cancer treated with concurrent chemoradiotherapy.基于 MRI 的放射组学预测同步放化疗治疗局部晚期宫颈鳞癌患者生存价值
Cancer Imaging. 2022 Jul 16;22(1):35. doi: 10.1186/s40644-022-00474-2.
4
Multiparametric magnetic resonance imaging-derived radiomics for the prediction of disease-free survival in early-stage squamous cervical cancer.基于多参数磁共振成像的影像组学用于预测早期宫颈鳞癌的无病生存期
Eur Radiol. 2022 Apr;32(4):2540-2551. doi: 10.1007/s00330-021-08326-6. Epub 2021 Oct 12.
5
Radiomics analysis for prediction of lymph node metastasis after neoadjuvant chemotherapy based on pretreatment MRI in patients with locally advanced cervical cancer.基于术前MRI的影像组学分析预测局部晚期宫颈癌患者新辅助化疗后淋巴结转移
Front Oncol. 2024 May 8;14:1376640. doi: 10.3389/fonc.2024.1376640. eCollection 2024.
6
MRI-based radiomic signatures for pretreatment prognostication in cervical cancer.基于 MRI 的放射组学特征用于宫颈癌的术前预后预测。
Cancer Med. 2023 Oct;12(20):20251-20265. doi: 10.1002/cam4.6526. Epub 2023 Oct 16.
7
Nomograms Combining Clinical and Imaging Parameters to Predict Recurrence and Disease-free Survival After Concurrent Chemoradiotherapy in Patients With Locally Advanced Cervical Cancer.列线图结合临床和影像学参数预测局部晚期宫颈癌同步放化疗后复发和无病生存
Acad Radiol. 2023 Mar;30(3):499-508. doi: 10.1016/j.acra.2022.08.002. Epub 2022 Aug 30.
8
MRI radiomics in overall survival prediction of local advanced cervical cancer patients tread by adjuvant chemotherapy following concurrent chemoradiotherapy or concurrent chemoradiotherapy alone.MRI 放射组学预测同步放化疗或单纯同步放化疗后辅助化疗的局部晚期宫颈癌患者总生存期。
Magn Reson Imaging. 2022 Sep;91:81-90. doi: 10.1016/j.mri.2022.05.019. Epub 2022 May 27.
9
Magnetic resonance imaging features of tumor and lymph node to predict clinical outcome in node-positive cervical cancer: a retrospective analysis.肿瘤和淋巴结的磁共振成像特征预测淋巴结阳性宫颈癌的临床结局:一项回顾性分析。
Radiat Oncol. 2020 Apr 20;15(1):86. doi: 10.1186/s13014-020-01502-w.
10
Pre-treatment MRI minimum apparent diffusion coefficient value is a potential prognostic imaging biomarker in cervical cancer patients treated with definitive chemoradiation.治疗前MRI最小表观扩散系数值是接受根治性放化疗的宫颈癌患者的一种潜在预后影像生物标志物。
BMC Cancer. 2016 Jul 28;16:556. doi: 10.1186/s12885-016-2619-0.

引用本文的文献

1
Pre-Treatment and Pre-Brachytherapy MRI first-order Radiomic Features by a Commercial software as survival predictors in radiotherapy for cervical cancer Objectives.使用商业软件提取的治疗前和近距离放疗前MRI一阶影像组学特征作为宫颈癌放疗生存预测指标 目的。
Clin Transl Radiat Oncol. 2025 Apr 19;53:100965. doi: 10.1016/j.ctro.2025.100965. eCollection 2025 Jul.
2
Longitudinal dynamic MRI radiomic models for early prediction of prognosis in locally advanced cervical cancer treated with concurrent chemoradiotherapy.用于同步放化疗治疗的局部晚期宫颈癌预后早期预测的纵向动态MRI影像组学模型
Radiat Oncol. 2024 Dec 21;19(1):181. doi: 10.1186/s13014-024-02574-8.
3

本文引用的文献

1
A multi-scanner study of MRI radiomics in uterine cervical cancer: prediction of in-field tumor control after definitive radiotherapy based on a machine learning method including peritumoral regions.多扫描仪研究宫颈癌 MRI 放射组学:基于包括肿瘤周围区域的机器学习方法预测根治性放疗后的肿瘤场内控制。
Jpn J Radiol. 2020 Mar;38(3):265-273. doi: 10.1007/s11604-019-00917-0. Epub 2020 Jan 6.
2
MRI-derived radiomics: methodology and clinical applications in the field of pelvic oncology.MRI 衍生的放射组学:在骨盆肿瘤领域的方法学和临床应用。
Br J Radiol. 2019 Dec;92(1104):20190105. doi: 10.1259/bjr.20190105. Epub 2019 Oct 10.
3
Pre-treatment T2-weighted magnetic resonance radiomics for prediction of loco-regional recurrence after image-guided adaptive brachytherapy for locally advanced cervical cancer.
治疗前T2加权磁共振影像组学用于预测局部晚期宫颈癌图像引导自适应近距离放疗后的局部区域复发
J Contemp Brachytherapy. 2024 Jun;16(3):193-201. doi: 10.5114/jcb.2024.141458. Epub 2024 Jun 28.
4
Artificial Intelligence in Obstetric and Gynecological MR Imaging.人工智能在妇产科磁共振成像中的应用
Magn Reson Med Sci. 2024 Oct 29. doi: 10.2463/mrms.rev.2024-0077.
5
Phase I/II prospective clinical trial for the hybrid of intracavitary and interstitial brachytherapy for locally advanced uterine cervical cancer.局部晚期宫颈癌腔内与间质插植混合近距离治疗的Ⅰ/Ⅱ期前瞻性临床试验。
J Gynecol Oncol. 2023 May;34(3):e24. doi: 10.3802/jgo.2023.34.e24. Epub 2022 Dec 21.
Predictors of Distant Metastasis in Patients with Cervical Cancer Treated with Definitive Radiotherapy.
接受根治性放疗的宫颈癌患者远处转移的预测因素
J Cancer. 2019 Jul 5;10(17):3967-3974. doi: 10.7150/jca.31538. eCollection 2019.
4
Repeatability and reproducibility of MRI-based radiomic features in cervical cancer.基于 MRI 的宫颈癌放射组学特征的可重复性和可再现性。
Radiother Oncol. 2019 Jun;135:107-114. doi: 10.1016/j.radonc.2019.03.001. Epub 2019 Mar 19.
5
Preoperative prediction of pelvic lymph nodes metastasis in early-stage cervical cancer using radiomics nomogram developed based on T2-weighted MRI and diffusion-weighted imaging.基于 T2 加权 MRI 和弥散加权成像的放射组学列线图术前预测早期宫颈癌盆腔淋巴结转移
Eur J Radiol. 2019 May;114:128-135. doi: 10.1016/j.ejrad.2019.01.003. Epub 2019 Mar 20.
6
Radiographic Number of Positive Pelvic Lymph Nodes as a Prognostic Factor in Cervical Cancer Treated With Definitive Concurrent Chemoradiotherapy or Intensity-Modulated Radiotherapy.盆腔阳性淋巴结的影像学数量作为接受根治性同步放化疗或调强放疗的宫颈癌患者的预后因素
Front Oncol. 2018 Nov 30;8:546. doi: 10.3389/fonc.2018.00546. eCollection 2018.
7
MR-Based Radiomics Nomogram of Cervical Cancer in Prediction of the Lymph-Vascular Space Invasion preoperatively.基于 MRI 的宫颈癌放射组学列线图术前预测淋巴结脉管间隙侵犯
J Magn Reson Imaging. 2019 May;49(5):1420-1426. doi: 10.1002/jmri.26531. Epub 2018 Oct 26.
8
Radiomics Analysis of Multiparametric MRI Evaluates the Pathological Features of Cervical Squamous Cell Carcinoma.多参数 MRI 放射组学分析评估宫颈鳞状细胞癌的病理特征。
J Magn Reson Imaging. 2019 Apr;49(4):1141-1148. doi: 10.1002/jmri.26301. Epub 2018 Sep 19.
9
Value of [F]FDG PET radiomic features and VEGF expression in predicting pelvic lymphatic metastasis and their potential relationship in early-stage cervical squamous cell carcinoma.[F]FDG PET 影像组学特征和 VEGF 表达在预测早期宫颈鳞癌盆腔淋巴结转移中的价值及其潜在关系。
Eur J Radiol. 2018 Sep;106:160-166. doi: 10.1016/j.ejrad.2018.07.024. Epub 2018 Jul 27.
10
Radiomic signature as a predictive factor for lymph node metastasis in early-stage cervical cancer.基于影像组学特征预测早期宫颈癌淋巴结转移
J Magn Reson Imaging. 2019 Jan;49(1):304-310. doi: 10.1002/jmri.26209. Epub 2018 Aug 13.